Jacques Izopet

InstitutionLaboratory of Virology
AddressToulouse
France
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 29 Covid-19 publications, with a maximum of 5 publications in June 2021
    All Publications
    Bar chart showing 484 publications over 28 distinct years, with a maximum of 33 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dimeglio C, Herin F, Miedougé M, Martin-Blondel G, Soulat JM, Izopet J. Protection of Healthcare Workers Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection. Clin Infect Dis. 2021 10 05; 73(7):1323-1324. PMID: 33503228.
      Citations: 5     Fields:    Translation:Humans
    2. Del Bello A, Marion O, Vellas C, Faguer S, Izopet J, Kamar N. Anti-SARS-CoV-2 Monoclonal Antibodies in Solid-organ Transplant Patients. Transplantation. 2021 10 01; 105(10):e146-e147. PMID: 34224543.
      Citations: 2     Fields:    Translation:Humans
    3. Chavarot N, Ouedrani A, Marion O, Leruez-Ville M, Vilain E, Baaziz M, Del Bello A, Burger C, Sberro-Soussan R, Martinez F, Chatenoud L, Abravanel F, Anglicheau D, Izopet J, Couat C, Zuber J, Legendre C, Lanternier F, Kamar N, Scemla A. Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept. Transplantation. 2021 09 01; 105(9):e94-e95. PMID: 33831941.
      Citations: 24     Fields:    Translation:HumansCells
    4. Del Bello A, Abravanel F, Marion O, Couat C, Esposito L, Lavayssière L, Izopet J, Kamar N. Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients. Am J Transplant. 2022 01; 22(1):322-323. PMID: 34331842.
      Citations: 13     Fields:    Translation:Humans
    5. Longlune N, Nogier MB, Miedougé M, Gabilan C, Cartou C, Seigneuric B, Del Bello A, Marion O, Faguer S, Izopet J, Kamar N. High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients. Nephrol Dial Transplant. 2021 08 27; 36(9):1704-1709. PMID: 34057463.
      Citations: 15     Fields:    Translation:Humans
    6. Dimeglio C, Herin F, Da-Silva I, Jougla I, Pradere C, Porcheron M, Martin-Blondel G, Chapuy-Regaud S, Izopet J. Heterologous ChAdOx1-S/BNT162b2 vaccination: neutralizing antibody response to SARS-CoV-2. Clin Infect Dis. 2021 Aug 12. PMID: 34383902.
      Citations: 3     Fields:    
    7. Migueres M, Vellas C, Abravanel F, Da Silva I, Dimeglio C, Ferrer V, Raymond S, Mansuy JM, Izopet J. Testing individual and pooled saliva samples for sars-cov-2 nucleic acid: a prospective study. Diagn Microbiol Infect Dis. 2021 Nov; 101(3):115478. PMID: 34364098.
      Citations:    Fields:    Translation:Humans
    8. Kamar N, Abravanel F, Marion O, Couat C, Izopet J, Del Bello A. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients. N Engl J Med. 2021 08 12; 385(7):661-662. PMID: 34161700.
      Citations: 110     Fields:    Translation:Humans
    9. Dimeglio C, Herin F, Da-Silva I, Porcheron M, Martin-Blondel G, Miedougé M, Izopet J. Strong SARS-CoV-2-neutralizing antibody response of previously-infected healthcare workers given one dose of mRNA vaccine. Clin Infect Dis. 2021 Jun 22. PMID: 34157078.
      Citations:    Fields:    
    10. Dimeglio C, Herin F, Miedougé M, Da-Silva I, Porcheron M, Martin-Blondel G, Soulat JM, Izopet J. One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection. J Infect. 2021 09; 83(3):381-412. PMID: 34147528.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    11. Dimeglio C, Loubes JM, Miedougé M, Herin F, Soulat JM, Izopet J. The real seroprevalence of SARS-CoV-2 in France and its consequences for virus dynamics. Sci Rep. 2021 06 15; 11(1):12597. PMID: 34131234.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    12. Del Bello A, Kamar N, Vergez F, Faguer S, Marion O, Beq A, Lathrache Y, Abravanel F, Izopet J, Treiner E. Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation. Kidney Int. 2021 10; 100(4):915-927. PMID: 34126110.
      Citations:    Fields:    Translation:HumansCells
    13. Dimeglio C, Nicot F, Miedougé M, Chappert JL, Donnadieu C, Izopet J. Influence of age on the spread of SARS-CoV-2 variant B.1.1.7. J Clin Virol. 2021 08; 141:104872. PMID: 34126543.
      Citations: 1     Fields:    Translation:Humans
    14. Marion O, Del Bello A, Abravanel F, Couat C, Faguer S, Esposito L, Hebral AL, Izopet J, Kamar N. Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants. Ann Intern Med. 2021 09; 174(9):1336-1338. PMID: 34029487.
      Citations: 20     Fields:    Translation:Humans
    15. Dimeglio C, Milhes M, Loubes JM, Ranger N, Mansuy JM, Trémeaux P, Jeanne N, Latour J, Nicot F, Donnadieu C, Izopet J. Influence of SARS-CoV-2 Variant B.1.1.7, Vaccination, and Public Health Measures on the Spread of SARS-CoV-2. Viruses. 2021 05 12; 13(5). PMID: 34066231.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    16. Dimeglio C, Collot S, Abravanel F, Sauné K, Lhomme S, Faruch M, Sans N, Izopet J. Diagnosis options in patients suffering from COVID-19-like symptoms. J Med Virol. 2021 Jul; 93(7):4076-4077. PMID: 33300117.
      Citations:    Fields:    Translation:Humans
    17. Mansuy JM, Bourcier M, Trémeaux P, Dimeglio C, Izopet J. COVID-19 pandemic period, where are the seasonal viruses? J Med Virol. 2021 Jul; 93(7):4097-4098. PMID: 33755234.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    18. Dimeglio C, Miedougé M, Loubes JM, Mansuy JM, Izopet J. Estimating the impact of public health strategies on the spread of SARS-CoV-2: Epidemiological modelling for Toulouse, France. Rev Med Virol. 2021 09; 31(5):1-8. PMID: 33713504.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    19. Dimeglio C, Miedougé M, Loubes JM, Mansuy JM, Izopet J. Side effect of a 6 p.m curfew for preventing the spread of SARS-CoV-2: A modeling study from Toulouse, France. J Infect. 2021 May; 82(5):186-230. PMID: 33535066.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    20. Martin-Blondel G, Ruiz S, Murris M, Faguer S, Faguer S, Duhalde V, Eyvrard F, Izopet J, Mansuy JM, Rolland Y, Delavigne K, Guimbaud R, Pugnet G, Conil JM, Georges B, Delobel P, Minville V, Minville V, Silva Sifontes S, Concordet D, Gandia P. Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics. Clin Infect Dis. 2020 12 31; 71(11):2962-2964. PMID: 32392332.
      Citations: 6     Fields:    Translation:Humans
    21. Dimeglio C, Loubes JM, Mansuy JM, Izopet J. Quantifying the impact of public health protection measures on the spread of SARS-CoV-2. J Infect. 2021 03; 82(3):414-451. PMID: 33129838.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    22. Dimeglio C, Herin F, Miedougé M, Cambus JP, Abravanel F, Mansuy JM, Soulat JM, Izopet J. Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France. J Infect. 2021 01; 82(1):e29-e32. PMID: 33010259.
      Citations: 5     Fields:    Translation:Humans
    23. Migueres M, Mengelle C, Dimeglio C, Didier A, Alvarez M, Delobel P, Mansuy JM, Izopet J. Saliva sampling for diagnosing SARS-CoV-2 infections in symptomatic patients and asymptomatic carriers. J Clin Virol. 2020 09; 130:104580. PMID: 32781366.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
    24. Trémeaux P, Lhomme S, Abravanel F, Raymond S, Mengelle C, Mansuy JM, Izopet J. Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens. J Clin Virol. 2020 08; 129:104541. PMID: 32659713.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    25. Abravanel F, Miédouge M, Chapuy-Regaud S, Mansuy JM, Izopet J. Clinical performance of a rapid test compared to a microplate test to detect total anti SARS-CoV-2 antibodies directed to the spike protein. J Clin Virol. 2020 09; 130:104528. PMID: 32771904.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    26. Dimeglio C, Mansuy JM, Charpentier S, Claudet I, Izopet J. Children are protected against SARS-CoV-2 infection. J Clin Virol. 2020 07; 128:104451. PMID: 32454427.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    27. Mansuy JM, Izopet J. We must not forget the most disadvantaged people facing the COVID-19 crisis. Public Health. 2020 06; 183:118. PMID: 32480325.
      Citations:    Fields:    
    28. Dimeglio C, Loubes JM, Deporte B, Dubois M, Latour J, Mansuy JM, Izopet J. The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France. J Infect. 2020 Aug; 81(2):318-356. PMID: 32360497.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    29. Vellas C, Delobel P, de Souto Barreto P, Izopet J. COVID-19, Virology and Geroscience: A Perspective. J Nutr Health Aging. 2020; 24(7):685-691. PMID: 32744561.
      Citations: 24     Fields:    Translation:HumansCellsPHPublic Health
    30. Mengelle C, Mansuy JM, Pierre A, Claudet I, Grouteau E, Micheau P, Sauné K, Izopet J. The use of a multiplex real-time PCR assay for diagnosing acute respiratory viral infections in children attending an emergency unit. J Clin Virol. 2014 Nov; 61(3):411-7. PMID: 25223920.
      Citations: 15     Fields:    Translation:HumansCells
    Izopet's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (352)
    Explore
    _
    Co-Authors (112)
    Explore
    _
    Similar People (60)
    Explore
    _